CureVac NV Company Insiders
| CVAC Stock | USD 4.66 0.01 0.21% |
CureVac NV employs about 825 people. The company is managed by 18 executives with a total tenure of roughly 1925 years, averaging almost 106.0 years of service per executive, having 45.83 employees per reported executive. Evaluation of CureVac NV's management performance can provide insight into the firm performance.
CureVac NV's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with CureVac NV's future performance. Based on our forecasts, it is anticipated that CureVac will maintain a workforce of about 830 employees by February 2026.CureVac NV Management Team Effectiveness
The company has return on total asset (ROA) of 0.2377 % which means that it generated a profit of $0.2377 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.4022 %, meaning that it created $0.4022 on every $100 dollars invested by stockholders. CureVac NV's management efficiency ratios could be used to measure how well CureVac NV manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.20. The current year's Return On Capital Employed is expected to grow to 0.23. At present, CureVac NV's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.20, whereas Total Assets are forecasted to decline to about 845 M.As of January 5, 2026, Common Stock Shares Outstanding is expected to decline to about 206.8 M. The current year's Net Loss is expected to grow to about (352 M)CureVac NV holds a total of 225.17 Million outstanding shares. Almost 89.49 percent of CureVac NV outstanding shares are held by general public with 0.09 (percent) owned by insiders and only 10.42 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2019-03-31 | Previous Quarter 225.2 M | Current Value 225.2 M | Avarage Shares Outstanding 198.9 M | Quarterly Volatility 21.7 M |
CureVac NV Workforce Comparison
CureVac NV is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 3,467. CureVac NV totals roughly 825 in number of employees claiming about 24% of equities under Health Care industry.
The company has Profit Margin (PM) of 1.82 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 5.73 %, which suggests for every 100 dollars of sales, it generated a net operating income of $5.73. CureVac NV Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CureVac NV Price Series Summation is a cross summation of CureVac NV price series and its benchmark/peer.
CureVac NV Notable Stakeholders
A CureVac NV stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CureVac NV often face trade-offs trying to please all of them. CureVac NV's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CureVac NV's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MD MBA | MD CEO | Profile | |
| Pierre BSc | CFO MD | Profile | |
| Patrick Baumhof | Senior Technology | Profile | |
| AxelSven Malkomes | Chief Officer | Profile | |
| Ronald Plasterk | Senior Innovation | Profile | |
| Igor MSc | Chief Board | Profile | |
| Antony Blanc | Chief MD | Profile | |
| Sarah Fakih | Vice Relations | Profile | |
| LLM LLM | Member CEO | Profile | |
| Thaminda Ramanayake | Chief Board | Profile | |
| Ulrike MD | Senior Oncology | Profile | |
| Slavica StevanovicHeck | Head Resources | Profile | |
| Thorsten Schuller | Head Communications | Profile | |
| HansGeorg Rammensee | Scientific Board | Profile | |
| Myriam MD | Head Officer | Profile | |
| Malte Greune | Member COO | Profile | |
| Marco LLM | General Counsel | Profile | |
| Marcus Dalton | Head Property | Profile |
About CureVac NV Management Performance
The success or failure of an entity such as CureVac NV often depends on how effective the management is. CureVac NV management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CureVac management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CureVac management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.19 | 0.20 | |
| Return On Capital Employed | 0.22 | 0.23 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 0.21 | 0.22 |
Please note, the presentation of CureVac NV's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CureVac NV's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CureVac NV's management manipulating its earnings.
CureVac NV Workforce Analysis
Traditionally, organizations such as CureVac NV use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CureVac NV within its industry.CureVac NV Manpower Efficiency
Return on CureVac NV Manpower
| Revenue Per Employee | 648.7K | |
| Revenue Per Executive | 29.7M | |
| Net Income Per Employee | 231.4K | |
| Net Income Per Executive | 10.6M | |
| Working Capital Per Employee | 550.4K | |
| Working Capital Per Executive | 25.2M |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |